Company Data

Outlook Therapeutics Inc.

Ticker
OTLK
Current Price
$1.08 1.89%
Market Cap
$244.2M
Price Target
Refer to Report
Volume
240.5K
52wk Range
$0.6839 - $2.12
Advanced Market Data

Overview

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.